| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0074-7742(06)78004-7 |
| P698 | PubMed publication ID | 17349859 |
| P50 | author | David A. Lewis | Q28112847 |
| P2093 | author name string | Takanori Hashimoto | |
| P2860 | cites work | An integrative theory of prefrontal cortex function | Q22337028 |
| A decrease of reelin expression as a putative vulnerability factor in schizophrenia | Q24657918 | ||
| Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex | Q28138248 | ||
| GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons | Q28142612 | ||
| Maturation of cognitive processes from late childhood to adulthood | Q28282268 | ||
| Excitatory effect of GABAergic axo-axonic cells in cortical microcircuits | Q28291599 | ||
| Essential role of brain-derived neurotrophic factor in adult hippocampal function | Q28593001 | ||
| Cortical inhibitory neurons and schizophrenia | Q29547683 | ||
| Cellular basis of working memory | Q29615398 | ||
| Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study | Q29616193 | ||
| Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia | Q29618963 | ||
| Volumes of association thalamic nuclei in schizophrenia: a postmortem study | Q30769853 | ||
| Synaptic targets of the intrinsic axon collaterals of supragranular pyramidal neurons in monkey prefrontal cortex | Q31791528 | ||
| Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. | Q51980100 | ||
| Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: volume, neuron number, and cell types. | Q52000103 | ||
| Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia | Q60644883 | ||
| Delayed response deficits produced by local injection of bicuculline into the dorsolateral prefrontal cortex in Japanese macaque monkeys | Q69650035 | ||
| [3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics | Q70158501 | ||
| Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex | Q71284796 | ||
| The distribution of brain-derived neurotrophic factor and its receptor trkB in parvalbumin-containing neurons of the rat visual cortex | Q71383340 | ||
| Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia | Q71972130 | ||
| Physiological subgroups of nonpyramidal cells with specific morphological characteristics in layer II/III of rat frontal cortex | Q72169950 | ||
| Neuronal activity and brain-derived neurotrophic factor regulate the density of inhibitory synapses in organotypic slice cultures of postnatal hippocampus | Q73119726 | ||
| Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus | Q73176583 | ||
| Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia | Q73535859 | ||
| Proximally targeted GABAergic synapses and gap junctions synchronize cortical interneurons | Q73567695 | ||
| No deficit in total number of neurons in the prefrontal cortex in schizophrenics | Q73711369 | ||
| Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus | Q74453176 | ||
| Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia | Q77437027 | ||
| Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex | Q81123595 | ||
| Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis | Q81461311 | ||
| Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia | Q32000373 | ||
| Abnormal neural synchrony in schizophrenia. | Q33764355 | ||
| Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. | Q33886021 | ||
| To model a psychiatric disorder in animals: schizophrenia as a reality test | Q33913794 | ||
| Schizophrenia as a disorder of neurodevelopment | Q34132313 | ||
| Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. | Q34214883 | ||
| Synchronization of neuronal activity in hippocampus by individual GABAergic interneurons. | Q34288636 | ||
| Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology | Q34328610 | ||
| Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder | Q34331509 | ||
| A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia. | Q35068136 | ||
| Subnucleus-specific loss of neurons in medial thalamus of schizophrenics | Q35203213 | ||
| Functional synergism between putative gamma-aminobutyrate-containing neurons and pyramidal neurons in prefrontal cortex | Q35210835 | ||
| Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction | Q35810087 | ||
| GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia | Q35916950 | ||
| A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia | Q36070114 | ||
| Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase | Q36190982 | ||
| Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations | Q36618870 | ||
| The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB. | Q37264937 | ||
| Differential synaptic localization of two major gamma-aminobutyric acid type A receptor alpha subunits on hippocampal pyramidal cells | Q37275701 | ||
| Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study | Q38362304 | ||
| What are the functional consequences of neurocognitive deficits in schizophrenia? | Q40976267 | ||
| Cortical development and thalamic pathology in schizophrenia | Q41609639 | ||
| Cortical degeneration in the absence of neurotrophin signaling: dendritic retraction and neuronal loss after removal of the receptor TrkB. | Q41734248 | ||
| Destabilization of cortical dendrites and spines by BDNF. | Q42474475 | ||
| Neurotrophins regulate dendritic growth in developing visual cortex | Q42479052 | ||
| Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus | Q43450226 | ||
| Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia | Q43601374 | ||
| Enforcement of temporal fidelity in pyramidal cells by somatic feed-forward inhibition | Q43703062 | ||
| The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. | Q43923756 | ||
| Postnatal development of parvalbumin- and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex | Q43994886 | ||
| Differential hippocampal expression of glutamic acid decarboxylase 65 and 67 messenger RNA in bipolar disorder and schizophrenia | Q44014143 | ||
| Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons. | Q44115048 | ||
| Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia | Q44129418 | ||
| Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins | Q44174112 | ||
| Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence | Q44240058 | ||
| Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs | Q44317351 | ||
| Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo | Q44320873 | ||
| Effects of a mediodorsal thalamus lesion on prefrontal inhibitory circuitry: implications for schizophrenia | Q44340950 | ||
| Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus | Q44355455 | ||
| Pyramidal neuron local axon terminals in monkey prefrontal cortex: differential targeting of subclasses of GABA neurons | Q44392682 | ||
| Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia | Q44507092 | ||
| Somal size of prefrontal cortical pyramidal neurons in schizophrenia: differential effects across neuronal subpopulations | Q44520878 | ||
| Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs | Q44530077 | ||
| Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex | Q44579696 | ||
| Serotonin1A receptors at the axon initial segment of prefrontal pyramidal neurons in schizophrenia | Q44824091 | ||
| GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia | Q44870602 | ||
| Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia | Q44926297 | ||
| Functional properties of fast spiking interneurons and their synaptic connections with pyramidal cells in primate dorsolateral prefrontal cortex. | Q45072824 | ||
| Neuropsychological deficits in schizophrenics. Relationship to age, chronicity, and dementia. | Q45173483 | ||
| Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. | Q45221811 | ||
| Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains | Q45251046 | ||
| Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease | Q45295751 | ||
| Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. | Q45307345 | ||
| A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. | Q46008223 | ||
| Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. | Q46022290 | ||
| Analysis of pyramidal neuron morphology in an inducible knockout of brain-derived neurotrophic factor | Q46430034 | ||
| Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia | Q46531764 | ||
| Cluster analysis-based physiological classification and morphological properties of inhibitory neurons in layers 2-3 of monkey dorsolateral prefrontal cortex | Q46575086 | ||
| Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy | Q46618162 | ||
| Regional specificity of chandelier neuron axon terminal alterations in schizophrenia. | Q46842674 | ||
| Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness. | Q46981404 | ||
| BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex | Q48104754 | ||
| Distribution and synaptic localization of immunocytochemically identified NMDA receptor subunit proteins in sensory-motor and visual cortices of monkey and human | Q48108089 | ||
| Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down | Q48135229 | ||
| Gamma oscillations correlate with working memory load in humans | Q48146164 | ||
| Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia | Q48186308 | ||
| Working memory deficit as a core neuropsychological dysfunction in schizophrenia | Q48186385 | ||
| A specific 'axo-axonal' interneuron in the visual cortex of the rat | Q48251394 | ||
| Synapse density regulates independence at unitary inhibitory synapses. | Q48342216 | ||
| Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression | Q48375420 | ||
| A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives | Q48438450 | ||
| Induced gamma-band activity during the delay of a visual short-term memory task in humans. | Q48455556 | ||
| The volume of the mediodorsal thalamic nucleus in treated and untreated schizophrenics. | Q48464550 | ||
| Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons | Q48675721 | ||
| Quantitative localization of NMDAR1 receptor subunit immunoreactivity in inferotemporal and prefrontal association cortices of monkey and human | Q48795099 | ||
| Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia | Q48826531 | ||
| Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging | Q48854560 | ||
| Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects | Q48855793 | ||
| Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics | Q48865852 | ||
| Glutamate decarboxylase(65)-immunoreactive terminals in cingulate and prefrontal cortices of schizophrenic and bipolar brain | Q49019867 | ||
| Heterogeneity of chandelier neurons in monkey neocortex: corticotropin-releasing factor- and parvalbumin-immunoreactive populations | Q49053064 | ||
| Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. | Q51014945 | ||
| Molecular and neuronal substrate for the selective attenuation of anxiety. | Q51376038 | ||
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 109-131 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | International Review of Neurobiology | Q15754273 |
| P1476 | title | Deciphering the disease process of schizophrenia: the contribution of cortical GABA neurons | |
| P478 | volume | 78 |
| Q48887866 | A novel mutation in the aristaless domain of the ARX gene leads to Ohtahara syndrome, global developmental delay, and ambiguous genitalia in males and neuropsychiatric disorders in females |
| Q45942819 | A transcranial magnetic stimulation study of the effects of cannabis use on motor cortical inhibition and excitability. |
| Q35760215 | Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia |
| Q37103350 | Afferent drive of medial prefrontal cortex by hippocampus and amygdala is altered in MAM-treated rats: evidence for interneuron dysfunction |
| Q36194890 | Annual Research Review: Development of the cerebral cortex: implications for neurodevelopmental disorders |
| Q34899462 | Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia. |
| Q28241328 | Cannabinoids and psychosis |
| Q24628837 | Cannabis and psychosis/schizophrenia: human studies |
| Q37679314 | Characteristics of the cation cotransporter NKCC1 in human brain: alternate transcripts, expression in development, and potential relationships to brain function and schizophrenia |
| Q39203819 | Clonazepam improves dopamine supersensitivity in a schizophrenia patient: a case report |
| Q49328625 | Cocaine-Induced Changes in Low-Dimensional Attractors of Local Field Potentials in Optogenetic Mice |
| Q36314731 | Cognition-emotion dysinteraction in schizophrenia |
| Q37292590 | Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia |
| Q90744653 | Dopamine receptor antagonists effects on low-dimensional attractors of local field potentials in optogenetic mice |
| Q48287343 | Epidermal growth factor signals attenuate phenotypic and functional development of neocortical GABA neurons. |
| Q47149753 | Evaluation of short interval cortical inhibition and intracortical facilitation from the dorsolateral prefrontal cortex in patients with schizophrenia |
| Q37135649 | Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia |
| Q36483365 | Functional hierarchy underlies preferential connectivity disturbances in schizophrenia |
| Q37707319 | GABA level, gamma oscillation, and working memory performance in schizophrenia |
| Q30455039 | GABA predicts inhibition of frequency-specific oscillations in schizophrenia. |
| Q38195925 | GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system. |
| Q39884127 | Genetic disruption of the autism spectrum disorder risk gene PLAUR induces GABAA receptor subunit changes. |
| Q33940105 | Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT |
| Q30387014 | Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications. |
| Q30873588 | In vivo magnetic resonance studies reveal neuroanatomical and neurochemical abnormalities in the serine racemase knockout mouse model of schizophrenia |
| Q90189126 | Inhibitory Plasticity: From Molecules to Computation and Beyond |
| Q47853823 | Input-Specific NMDAR-Dependent Potentiation of Dendritic GABAergic Inhibition |
| Q35052007 | Integrated brain circuits: astrocytic networks modulate neuronal activity and behavior |
| Q36290045 | Interneuron Transcriptional Dysregulation Causes Frequency-Dependent Alterations in the Balance of Inhibition and Excitation in Hippocampus. |
| Q36379415 | Interneuronal DISC1 regulates NRG1-ErbB4 signalling and excitatory-inhibitory synapse formation in the mature cortex |
| Q38239291 | Localized GABAergic inhibition of dendritic Ca(2+) signalling |
| Q30454958 | Modeling resilience to schizophrenia in genetically modified mice: a novel approach to drug discovery |
| Q34616459 | Neonatal nicotine exposure increases excitatory synaptic transmission and attenuates nicotine-stimulated GABA release in the adult rat hippocampus |
| Q93023762 | Normalization of mediotemporal and prefrontal activity, and mediotemporal-striatal connectivity, may underlie antipsychotic effects of cannabidiol in psychosis |
| Q92150126 | Preserving the balance: diverse forms of long-term GABAergic synaptic plasticity |
| Q24601700 | Probing GABA Receptor Function in Schizophrenia with Iomazenil |
| Q33342753 | Protein expression in the nucleus accumbens of rats exposed to developmental vitamin D deficiency |
| Q33319373 | Proteomic analysis of membrane microdomain-associated proteins in the dorsolateral prefrontal cortex in schizophrenia and bipolar disorder reveals alterations in LAMP, STXBP1 and BASP1 protein expression. |
| Q33729678 | Renewed focus on the developing human neocortex |
| Q42723397 | Schizophrenia and the epigenetic hypothesis |
| Q28727394 | Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse |
| Q22251476 | Schizophrenia, “Just the Facts”: What we know in 2008 |
| Q34217453 | Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice |
| Q30455955 | Spatiotemporal and frequency domain analysis of auditory paired stimuli processing in schizophrenia and bipolar disorder with psychosis |
| Q37850530 | Synaptic changes in the brain of subjects with schizophrenia. |
| Q37792525 | The Development Of The Science Of Dreaming |
| Q24596842 | The GABA B receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice |
| Q34069164 | The future of ultra-high field MRI and fMRI for study of the human brain |
| Q34513495 | The largest group of superficial neocortical GABAergic interneurons expresses ionotropic serotonin receptors. |
| Q46349804 | Transcriptional dysregulation causes altered modulation of inhibition by haloperidol |
| Q36332602 | Using human brain imaging studies as a guide toward animal models of schizophrenia. |
Search more.